Modern Age Review
Best for: Patients wanting a premium, branded-GLP-1 weight program inside a longevity clinic.
Modern Age is a longevity-focused health clinic that uses FDA-approved branded GLP-1 medication (semaglutide - Wegovy/Ozempic) within a structured Weight Loss Program. The model is assessment-led: an Aging Wellness Assessment ($500) with blood draw, at-home tests and a one-hour board-certified clinician review, followed by a personalized 6-month Weight Loss Program ($500). GLP-1 medication is not included; if uninsured, branded Ozempic/Wegovy is estimated at $900-1600/mo. Currently available to residents in 16 states. A premium, clinician-led program, not a low-cost compounded subscription.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Modern Age is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Modern Age prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| all doses (medication billed separately) | brand | $900 |
✓ Pros
- •Uses FDA-approved branded GLP-1 medication (Wegovy/Ozempic), no compounding
- •Comprehensive assessment with labs, at-home tests and clinician review
- •Board-certified clinicians and structured 6-month program
- •Longevity-oriented, whole-person approach beyond weight loss
✗ Cons
- •Expensive: $500 assessment plus $500 program, with medication billed separately
- •Branded GLP-1 can cost $900-1600/mo if not covered by insurance
- •Only available in 16 states (specific states not listed publicly)
- •Premium positioning makes it costlier than compounded-subscription rivals
Ready to start with Modern Age?
Starting at $900/month. See current pricing and start your free consultation.
Sources & methodology
Our Modern Age review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to Modern Age
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Modern Age?
Starting at $900/month. See current pricing and start your free consultation.